cro.directory
← Compare landing

Cellentia, Inc. vs Genevoyager (Wuhan) Co., Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cellentiabio/genevoyager-2

CategoryCellentia, Inc.Genevoyager (Wuhan) Co., Ltd.
Listed sitecroboth
SummaryCellentia is a specialized contract research organization offering custom bioassay development, patient-derived 3D tumor organoid models, AAV and MSD assays, PBMC isolation, and mycoplasma detection services to support drug discovery and translational research.Leading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023.
Services
  • Translational Research
  • Biomarker Assays
  • In Vitro Pharmacology
  • Translational Research
  • Analytical Method Development & Validation
  • Regulatory Affairs
Modalities
  • AAV / Viral Vector Platform
  • Biologics (Other)
  • Vaccine
  • AAV / Viral Vector Platform
Indications
  • Oncology
Data not yet provided.
Locations
  • Headquarters, Mountain View, California, United States
  • Headquarters & cGMP Facility, Wuhan, Jiangxia District, China
CertificationsData not yet provided.
  • China · Identifier: High-tech Enterprise (高新技术企业)
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.